Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Website Related Posts Initial Exploration Program Completed at Cosmo Gold Project April 29, 2025 What is the VIX Index? April 29, 2025 4 Biggest Cybersecurity ETFs in 2025 April 29, 2025